The agencys response to CCHRs reports of the drugs dangers and growing public concern was a 1991 review by its Psychopharmacological Drugs Advisory Committee.
But the review turned out to be nothing short of a whitewash. Dozens of Prozac victims or their surviving family members told the FDA committee of horror stories linking the drug to multiple murders, suicides and other nightmarish effects. Yet the panel voted to do nothing. It was later documented that at least five of the 10 committee members had conflicts of interest at the time they reviewed Prozac. But, it seemed, the FDAs cover-up was complete.
And what was Lillys response? Not to do anything about either the drug or the lives that were being destroyed. Instead, the motif was a familiar one: Kill the messenger.
The firm launched a multi-pronged, international and ultimately unsuccessful public relations offensive against both CCHR and the Church of Scientology. As documented in court
records, it included both their own literature
and messages carried by other media, most notably Time magazine.
More recently, the FDA took its protection of a deadly drug to a new low at the expense of the public good. In November 1996, the agency rubber-stamped Prozac for use in treating bulimia.
Before that year had even begun, the FDA had reportedly received more than 35,230 reports of adverse reactions to the drug. But no one at the agency was moved to action, even when the number shot past the 40,000 mark.
The result: Many parties went to the courts for justice after loss or injury of a loved one linked to the drug. Among them were the survivors and relatives of Joseph Wesbeckers onslaught.
| Previous | Glossary of Scientology Terms | Contents | Next |
| Your view on this Scientology Website | Scientology Related Sites | Bookstore | Church of Scientology Freedom Magazine |
For Trademark Information